Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Northrop Grumman | NOC | Nov 27, 2024 | 489.08 | +0.13 |
NorthView Acquisition | NVAC | Nov 27, 2024 | 11.71 | 0.00 |
Northwest Bancshares | NWBI | Nov 27, 2024 | 14.80 | -0.27 |
Northwest Natural Holdings | NWN | Nov 27, 2024 | 43.34 | +0.12 |
Northwest Pipe | NWPX | Nov 27, 2024 | 56.39 | +0.79 |
NorthWestern Energy | NWE | Nov 27, 2024 | 54.72 | +0.44 |
Norwegian Cruise Line | NCLH | Nov 27, 2024 | 26.92 | -0.96 |
Norwood Financial | NWFL | Nov 27, 2024 | 30.87 | +1.71 |
Notable Labs | NTBL | Nov 27, 2024 | 0.34 | 0.00 |
Nouveau Monde Graphite | NMG | Nov 27, 2024 | 1.27 | +1.20 |
NOV | NOV | Nov 27, 2024 | 15.99 | -0.06 |
Nova | NVMI | Nov 27, 2024 | 172.39 | -1.23 |
Nova Lifestyle | NVFY | Nov 27, 2024 | 0.50 | -3.72 |
Nova Minerals | NVA | Nov 27, 2024 | 9.60 | +3.78 |
Nova Vision Acquisition | NOVV | Nov 27, 2024 | 37.00 | 0.00 |
Novabay Pharmaceuticals | NBY | Nov 27, 2024 | 0.59 | -2.20 |
Novagold Resources | NG | Nov 27, 2024 | 3.58 | +0.28 |
Novanta | NOVT | Nov 27, 2024 | 164.03 | -1.55 |
Novartis ADR | NVS | Nov 27, 2024 | 104.87 | +1.02 |
Novavax | NVAX | Nov 27, 2024 | 8.62 | -1.49 |
Novo Integrated Sciences | NVOS | Nov 27, 2024 | 0.17 | 0.00 |
Novo Nordisk ADR | NVO | Nov 27, 2024 | 106.13 | 0.00 |
NovoCure | NVCR | Nov 27, 2024 | 19.69 | +10.12 |
Novonix ADR | NVX | Nov 27, 2024 | 1.98 | -26.39 |
NRG Energy | NRG | Nov 27, 2024 | 98.89 | -2.24 |
NRx Pharmaceuticals | NRXP | Nov 27, 2024 | 1.29 | +1.57 |
NSTS Bancorp | NSTS | Nov 27, 2024 | 11.20 | -0.71 |
Nu Holdings | NU | Nov 27, 2024 | 13.53 | -2.94 |
Nu Skin Enterprises | NUS | Nov 27, 2024 | 7.69 | +3.36 |
Nuburu | BURU | Nov 27, 2024 | 0.46 | +2.06 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.